Other names: Lagevrio
Categories: Prescription Medication
Description:
Molnupiravir is an oral antiviral medication used to treat mild to moderate COVID-19 in adults at high risk of severe illness. It must be started within 5 days of symptom onset and is taken as capsules for 5 days. While it can reduce the risk of hospitalization, it is generally considered less effective than other treatments like Paxlovid.
Molnupiravir is used to treat COVID-19 when Paxlovid isn’t suitable—such as in patients with certain drug interactions, or kidney or liver problems. While it’s less effective than Paxlovid, it’s a useful backup option when other treatments aren’t safe or available.
Treatment For:
AI generated Summary: Based on the single review provided, Molnupiravir appears to be a valuable oral antiviral treatment for COVID-19, particularly when other treatments like Paxlovid are not suitable due to drug interactions or kidney/liver issues. Although less effective than Paxlovid, Molnupiravir serves as an important alternative treatment option.
Molnupiravir is an oral antiviral for COVID-19, used when Paxlovid isn’t appropriate due to drug interactions or kidney/liver issues. While less effective than Paxlovid, it’s a valuable alternative when other treatments aren’t suitable.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
